759 days ago
Cenkos is house broker to Optibiotix (OPTI) so it is biased. I own shed loads of shares so am biased. The forecasts in the note out today include sod all for the three major deals announced at Christmas. So they will be increased. Read into this what you want. My pension will be buying more shares at around the current level if it can.
1075 days ago
This is a tale which leaves no one involved, other than Open Orphan PLC (ORPH), looking like angels. It is also an invitation to you from Sam Allen at Walbrook PR to front run a broker upgrade.
1754 days ago
Caveat 1: SP Angel which produced this note is house broker to Union Jack Oil (UJO) so is biased. Caveat 2: Zac Phillips no longer works at SP Angel and the new analyst is not fit to lick Zac’s boots. Caveat 3: Chris Oil owns stacks of these shares and will sell into any spike while urging others to buy like the dirty little spiv he is. Having said all iof that I can’t fault the logic of this detailed note.
2477 days ago
The house broker on AIM earns its money not from investors but from corporates. It banks £2-4,000 a month as a retainer and then makes 5% commission on any funds it raises. Lovely jubbly, coke and hookers all round. Of course that makes its research less than impartial. Prostitutes do not tell their clients that they have a small dick and so you would not expect Arden Partners to conclude that shares in Mercantile Ports & Logistics (MPL) are worthless crap, which they are. Welcome to a strong contender for the worst research note of the year to date.
2489 days ago
Beaufort Securities acts as house broker to Solo Oil (SOLO) so it is paid to write research on the company. Think of the relationship as being like that as between a hooker and a punter. The punter pays the bills. The hooker assures him that he is hung like a donkey. With that minor caveat I bring you a fairly detailed note from research analyst Charles Long at Beaufort out today. Apparently the shares, now 0.24p are worth 0.91p. But Hang on Henry...
2623 days ago
The fragrant Alice Lane, a foxy young brokerette who apparently I once reduced to tears by being so beastly, is this morning disseminating the latest FinnCap note on Premaitha (NIPT) to clients. Since it is bullish I am happy to make it up to Alice by exposing this high quality research to a wider audience, especially since we own more than a few shares. By way of balance i should say that FinnCap is house broker and therefore utterly partial and you can feel free to ignore every word of this report.
2687 days ago
It is now 11 days since I published details of leaked emails which showed that AIM scumbag Advanced Oncotherapy had withheld awful trading news from investors as the company launched an open offer. That is clearly securities fraud. Almost as bad, the emails showed that the timelines the company had held out to both customers in China and investors in London for product delivery were just fantasy. And that is why customers walked. Heads should have rolled. Hapless Nomad Stockdale should have forced a statement. And having told its house broker (Beaufort) that a much needed refinancing would happen by the year end, we need an update on that too. Instead...
2736 days ago
This website has pointed out that AIM listed IGAS has been a slam dunk sell for more than two years but for a good few months as it warned that it would breach covenants on its bonds any moron could see that the writing was on the wall. Except loyal house broker Cannacord, shamed over the Quindell fraud, its research on this has been laughable. It shows that a buy note from a house broker, especially one as shoddy as Cannacord, is just worthless. You will remember how Canaccord fired heroic Kevin Ashton, the world's number 1 tech analyst, when he refused to write a buy note on the Quindell fraud.
3506 days ago
Shares in China based AIM listed fraud Naibu have slumped to just 23p today – they were 50p on Thursday before the disastrous interims were published. House broker and Nomad Daniel Stewart (the firm that signed off on the Quenron IPO) stated on Friday that earnings will be 46p this year and that fair value is 50p. So why is it not rating the stock as a buy?
Surely a PE of just 0.45 and share price upside of 140% makes this a screaming buy. The only problem, as Daniel Stewart knows full well, is that this is a fraud
